Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
about
Clinical Trials in Branch Retinal Vein OcclusionAn Endovascular Cannulation Needle with an Internal Wire for the Fragmentation of Thrombi in Retinal Vein OcclusionFundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseasesAflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion.Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare PerspectiveDexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery.New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionClinical Applications of Dexamethasone for Aged Eyes.Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result.One-year treatment outcomes of ziv-aflibercept for treatment-naïve macular oedema in branch retinal vein occlusion.Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients.Real world evidence of use of anti-VEGF therapy in Denmark.Reduced light sensitivity due to impaired retinal perfusion in branch retinal vein occlusion.Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2).A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.Recent advances in understanding and managing retinal vein occlusions.The use of bevacizumab and ranibizumab for branch retinal vein occlusion in medicare beneficiaries.
P2860
Q26767092-6E09676D-B798-40A3-A82B-3EA78917EF0CQ30372587-47D6C58E-B9A7-4211-BC73-358F88C81C9FQ33840787-061849E1-616B-4B07-876B-1937288BBCA3Q36331045-DA16CF3A-2D04-48F9-8994-EC869F031225Q36526922-E572D22F-B412-4021-9688-91E6F5E4FC1BQ37723180-12ED6345-4058-4BE0-8F65-32B018BF8AE3Q38402203-C90E60B3-6B67-44F1-B79E-AF1ED464449BQ38848800-8DBB938D-1F8C-48F1-B26A-4893C1C6B307Q38938500-AE728C7B-9F85-46AA-8448-33B13D49CC6FQ47132309-905922B4-2776-4C56-9F68-F998C6D90C3EQ47663669-2D08C658-DC00-41A8-A57F-5E6627C8DF6DQ48329596-658D3128-92AF-4F78-9FC7-880ACA1073A8Q49619345-DFD8AFE3-1AB3-4208-9FA7-EEE005333554Q49696877-3F323E6D-D223-40B3-87F4-0A1A4FD7EB9FQ50571685-C608EAF4-1439-489A-BB21-F39CFCA70929Q51790950-4424BF4F-E98E-46F3-A991-BB857C301E30Q52584491-912CE807-F30D-4C2C-BBF4-049F84DD39F9Q53199049-24AD6D5C-78C4-412E-86CB-71D3664BED1AQ55283872-8C29575D-9A0A-4843-B724-F7B369FA1B60Q55551050-E4A1C80E-8D1C-4597-8D20-F4D8ABC9A480
P2860
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@ast
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@en
type
label
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@ast
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@en
prefLabel
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@ast
Intravitreal Aflibercept for M ...... Results of the VIBRANT Study.
@en
P2093
P1433
P1476
Intravitreal Aflibercept for M ...... k Results of the VIBRANT Study
@en
P2093
Alyson J Berliner
David M Brown
Husain Kazmi
Julia A Haller
Karen W Chu
Kristine Erickson
Peter A Campochiaro
Robert Vitti
W Lloyd Clark
Yenchieh Cheng
P304
P356
10.1016/J.OPHTHA.2015.09.035
P577
2015-10-30T00:00:00Z